CSL says will look for other opportunities
SYDNEY, June 9 |
SYDNEY, June 9 (Reuters) - Australian blood products group CSL Ltd (CSL.AX) is in a strong position and will be looking for other opportunities, Chief Executive Officer Brian McNamee told a media briefing on Tuesday.
CSL has dropped plans to buy U.S. rival Talecris Biotherapeutics Holdings Corp. For details: ID:nSYU006652]. ($1=A$1.27) (Reporting by Denny Thomas;) ((denny.thomas@reuters.com; +61 2 9373 1812; Reuters Messaging: denny.thomas.reuters.com@reuters.net)) ((If you have a query or comment on this story, send an email to news.feedback.asia@thomsonreuters.com))
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters